Consolidated Portfolio Review Corp Makes New Investment in Healthpeak Properties, Inc. (NYSE:DOC)

Consolidated Portfolio Review Corp bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 52,263 shares of the real estate investment trust’s stock, valued at approximately $1,195,000.

Several other hedge funds also recently made changes to their positions in the business. Point72 Asia Singapore Pte. Ltd. bought a new position in Healthpeak Properties in the 2nd quarter valued at about $66,000. Point72 DIFC Ltd acquired a new position in Healthpeak Properties during the second quarter valued at approximately $161,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Healthpeak Properties during the second quarter valued at approximately $9,024,000. Centaurus Financial Inc. bought a new stake in Healthpeak Properties during the second quarter worth $227,000. Finally, Massmutual Trust Co. FSB ADV acquired a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $108,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Trading Down 3.1 %

Shares of NYSE:DOC traded down $0.71 during midday trading on Friday, reaching $22.29. The company’s stock had a trading volume of 8,802,307 shares, compared to its average volume of 4,002,954. The firm has a 50 day moving average price of $22.26 and a two-hundred day moving average price of $20.66. Healthpeak Properties, Inc. has a fifty-two week low of $15.24 and a fifty-two week high of $23.26. The firm has a market capitalization of $15.59 billion, a price-to-earnings ratio of 47.43, a PEG ratio of 3.30 and a beta of 1.14. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.23). The company had revenue of $695.50 million during the quarter, compared to the consensus estimate of $665.11 million. Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. The business’s revenue was up 27.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.45 EPS. As a group, analysts forecast that Healthpeak Properties, Inc. will post 1.79 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be given a dividend of $0.30 per share. The ex-dividend date is Monday, November 4th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.38%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 255.32%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Evercore ISI lifted their target price on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, September 16th. Wedbush raised their target price on shares of Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research report on Monday, July 29th. Deutsche Bank Aktiengesellschaft upgraded shares of Healthpeak Properties from a “hold” rating to a “buy” rating and upped their price target for the stock from $20.00 to $28.00 in a report on Monday, October 21st. Royal Bank of Canada boosted their price objective on Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 30th. Finally, Citigroup increased their target price on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $22.62.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.